四川双马间接控股子公司5亿元项目环评获原则同意

Group 1 - The core point of the news is that Sichuan Shuangma (000935) has received preliminary approval for the environmental assessment of its subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd.'s peptide drug expansion project, with a total investment of 500 million yuan [1] - The "A-share Green Report" project aims to enhance the transparency of environmental information for listed companies by monitoring their environmental performance based on authoritative regulatory data from 31 provinces and 337 cities [1] - The latest issue of the A-share Green Weekly Report indicated that six listed companies have recently exposed environmental risks [1]